Q1 2025 Earnings Summary
Metric | YoY Change | Reason |
---|---|---|
Total Revenue | -1.4% | Total Revenue declined from $606.67M in Q1 2024 to $598.1M in Q1 2025, largely driven by weaker international revenue, while US revenue remained stable. The slight drop suggests that challenges abroad may have weighed on overall performance. |
United States Revenue | 0% | US Revenue was virtually unchanged at $483.9M in Q1 2025 compared to $482.93M in Q1 2024. This consistency indicates a robust domestic market and steady customer demand, though the documents provide no further specifics. |
International Revenue | -7.6% | International Revenue fell from $123.74M in Q1 2024 to $114.3M in Q1 2025. This significant decline points to potential external challenges such as tougher market conditions or competitive pressures overseas, but precise business or market factors were not detailed. |
Research analysts covering GLOBUS MEDICAL.